Tennessee Valley Asset Management Partners’s Pfizer PFE Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,236	Closed	-$35.6K	–	552
2023 Q4	$35.6K	Buy	+1,236	New	+$37.4K	﹤0.01%	272

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tennessee Valley Asset Management Partners's PFE Position: Q1 2024 in Review

Tennessee Valley Asset Management Partners sold out of Pfizer (PFE) in Q1 2024, closing a stake of 1,236 shares — an estimated $35.6K sold.

Tennessee Valley Asset Management Partners first reported a position in PFE in Q4 2023 and held it in 1 quarter. The position peaked at $35.6K in Q4 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Tennessee Valley Asset Management Partners reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Tennessee Valley Asset Management Partners sold 1,236 Pfizer shares in Q1 2024, an estimated $35.6K.
Tennessee Valley Asset Management Partners first reported a position in Pfizer in Q4 2023 and held it in 1 quarter.
Tennessee Valley Asset Management Partners's Pfizer position peaked at $35.6K in Q4 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2024, filed 23 Apr 2024.